abstract |
The present invention relates to a novel precursor drug (prodrug) or a pharmaceutically acceptable salt thereof of the edaravone compound, a pharmaceutical composition comprising them as an active ingredient, and a treatment or improvement drug for neurodegenerative and/or motor neuron diseases thereof provide use. |